NextRNA Therapeutics
Cambridge, US · Founded 2019 · Delaware corporation · 1 known investors
Founders & leadership
CN
Carl NovinaNamed on SEC filing
EP
Elena ProkupetsNamed on SEC filing
BP
Barry PoliskyNamed on SEC filing
AA
Andrea ArmstrongNamed on SEC filing
DV
Dominique VerhelleNamed on SEC filing
CH
Christine HendersonNamed on SEC filing
SL
Susan LangerNamed on SEC filing
FM
Fred MermelsteinNamed on SEC filing
KA
Kenneth AndersonNamed on SEC filing
DD
Drew DennisonNamed on SEC filing
Board
AB
MA
Investors · 1
Reported raises · per SEC filings
Form D private placements$23.4M disclosed across 1 round · 2022
▶$23.4MraisedJan 2022 · 34 investors · BiotechnologyRule 506(b)
▶$23.4MraisedJan 2022 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl NovinaDirector
- Elena ProkupetsDirector
- Barry PoliskyDirector
- Andrea ArmstrongDirector
- Arthur BeckerDirector
- Dominique VerhelleDirector
- Marc A. CohenExecutive Officer, Director
- Christine HendersonDirector
- Susan LangerDirector
- Fred MermelsteinDirector
- Kenneth AndersonDirector
- Drew DennisonDirector
- Malcolm SalterDirector
- Julia NovinaExecutive Officer
- Alain CohenDirector
- Offering amount
- $50M
- Amount sold
- $23.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through NextRNA Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are NextRNA Therapeutics's investors?
- NextRNA Therapeutics's investors include Cobro Ventures.
- How much funding has NextRNA Therapeutics raised?
- NextRNA Therapeutics has disclosed $23.4M raised across 1 round.
- Where is NextRNA Therapeutics headquartered?
- NextRNA Therapeutics is headquartered in Cambridge, US.